|
|
 |
|
Viewing report
|
|
|
|
Mylan Inc. - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011, Pages: 173
Mylan Inc. – Product Pipeline Review – H2 2011
Summary
Global Market Direct’s pharmaceuticals report, “Mylan Inc. - Product Pipeline Review - H2 2011” provides data on the Mylan Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Mylan Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Mylan Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Mylan Inc. - Brief Mylan Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Mylan Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Mylan Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Mylan Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Mylan Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Mylan Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Mylan Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Mylan Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Mylan Inc. and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of Mylan Inc.; Mylan Inc. - Key Therapeutics; Mylan Inc. - Pipeline Overview and Promising Molecules; Mylan Inc. - News; Mylan Inc. - Latest Updates; Mylan Inc. - Pipeline; Mylan Inc. - Discontinued/Dormant Projects
|
|
|
|
